Position in BIIB
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$39,495,881
-$3,741,340 QoQ
Shares Held
215,436
-12.3% QoQ
Ownership
0.146%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026BNP PARIBAS ASSET MANAGEMENT Holding S.A. holds $4,969,350,861 across 12 Drug Manufacturers - General names. BIIB ranks #10 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
7,624,427 | $1,503,689,491 | |
| 2 | LLY |
ELI LILLY & Co
|
1,157,476 | $1,064,611,698 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
4,423,414 | $616,491,207 | |
| 4 | JNJ |
Johnson & Johnson
|
1,642,509 | $401,494,898 | |
| 5 | ABBV |
AbbVie Inc.
|
1,491,841 | $324,460,498 | |
| 6 | MRK |
Merck & Co., Inc.
|
2,316,095 | $278,603,066 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,407,916 | $267,340,104 | |
| 8 | AMGN |
Amgen Inc
|
741,006 | $260,722,960 |
All Filings in BIIB
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $39,495,881 | 215,436 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $43,237,221 | 245,680 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $27,582,172 | 196,903 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $20,550,291 | 163,630 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $20,880,826 | 152,593 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $27,291,326 | 178,468 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $77,420,470 | 399,404 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $100,341,431 | 432,842 | Shares | Defined | 2024-07-30 | |
| 2024-03-31 | $123,024,029 | 570,533 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $116,040,748 | 448,432 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $169,766,926 | 660,546 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $157,153,167 | 551,705 | Shares | Defined | 2023-08-08 | |
| 2023-03-31 | $113,689,802 | 408,912 | Shares | Defined | 2023-05-08 | |
| 2022-12-31 | $106,727,737 | 385,410 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $92,540,064 | 346,592 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $70,982,131 | 348,054 | Shares | Defined | 2022-08-04 | |
| 2022-03-31 | $73,081,779 | 347,017 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $58,459,386 | 243,662 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $85,740,310 | 302,980 | Shares | Defined | 2021-11-08 | |
| 2021-06-30 | $90,469,961 | 261,270 | Shares | Defined | 2021-08-05 | |
| 2021-03-31 | $80,914,889 | 289,240 | Shares | Defined | 2021-05-05 | |
| 2020-12-31 | $63,350,424 | 258,721 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $71,007,089 | 250,307 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $41,956,120 | 156,816 | Shares | Defined | 2020-08-04 | |
| 2020-03-31 | $53,420,762 | 168,850 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||